(VHT) Vanguard Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US92204A5048 • Health
VHT: Healthcare, Equities, Index, Stocks, Companies
The Vanguard Health Care Index Fund ETF Shares (NYSE ARCA: VHT) is designed to replicate the performance of a broad index of U.S. healthcare companies, classified under the Global Industry Classification Standard (GICS). The fund includes stocks of large-cap, mid-cap, and small-cap companies across sectors such as pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. By closely tracking the target index, the fund aims to deliver returns that align with the overall healthcare sector.
The ETF employs a full-replication approach, meaning it holds securities in the same proportions as the underlying index. This strategy minimizes tracking error and ensures diversification across the healthcare industry. The funds assets under management (AUM) total approximately $15.1 billion, making it one of the largest healthcare-focused ETFs available to investors.
3-Month Forecast: Based on
Additional Sources for VHT ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VHT ETF Overview
Market Cap in USD | 15,096m |
Category | Health |
TER | 0.10% |
IPO / Inception | 2004-01-26 |
VHT ETF Ratings
Growth Rating | 43.2 |
Fundamental | - |
Dividend Rating | 56.4 |
Rel. Strength | -9.33 |
Analysts | - |
Fair Price Momentum | 234.45 USD |
Fair Price DCF | - |
VHT Dividends
Dividend Yield 12m | 1.53% |
Yield on Cost 5y | 2.31% |
Annual Growth 5y | 7.36% |
Payout Consistency | 96.0% |
VHT Growth Ratios
Growth Correlation 3m | -84.2% |
Growth Correlation 12m | -17.6% |
Growth Correlation 5y | 80.2% |
CAGR 5y | 8.17% |
CAGR/Max DD 5y | 0.46 |
Sharpe Ratio 12m | -0.10 |
Alpha | -7.01 |
Beta | 0.553 |
Volatility | 26.41% |
Current Volume | 153.3k |
Average Volume 20d | 251k |
As of May 01, 2025, the stock is trading at USD 255.89 with a total of 153,349 shares traded.
Over the past week, the price has changed by +3.65%, over one month by -3.34%, over three months by -5.16% and over the past year by +1.44%.
Partly, yes. Based on ValueRay Analyses, Vanguard Health Care (NYSE ARCA:VHT) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.15 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VHT as of May 2025 is 234.45. This means that VHT is currently overvalued and has a potential downside of -8.38%.
Vanguard Health Care has no consensus analysts rating.
According to ValueRays Forecast Model, VHT Vanguard Health Care will be worth about 261.3 in May 2026. The stock is currently trading at 255.89. This means that the stock has a potential upside of +2.11%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 261.3 | 2.1% |